1989
|
Sign up to set email alerts
Primary non-Hodgkin's lymphoma of the stomach: Changing aspects and therapeutic choices
Search citation statements
Order By: Relevance
Paper Sections
Select...
52
4
2
1
Citation Types
3
15
0
0
Year Published
Range
1990
19902023
2023Publication Types
Select...
48
9
Relationship
0
57
Authors
Journals
Cited by 57 publications
(18 citation statements)
References 17 publications
3
15
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our results showed an 88% 5-year disease-free survival, which com pares favorably with the results reported for other patients with stage IE disease (most with intermediate histology) treated with various regimens during a similar time peri od [11,12,23,24], Optimal treatment for patients with intermediate histology is unresolved. In contrast to the report of Valicenti et al [24], in which most of the patients had local failure, our results showed that these patients had distant failure, suggesting that there may be a role for systemic treatment.…”
Section: Intermediate-histology Lymphoma
supporting
confidence: 79%
“…The results reported by Maor et al [11] and Burgers et al [ 19] are comparable to the results of series in which patients underwent gastrectomy with or without adjuvant treatment [2.4,9,10,12,15,20-23] and suggest that initial management with radiation with or without chemotherapy may produce comparable diseasefree survival and overall survival as compared with regi mens that include surgical treatment. Both Taal et al [12] and Valicenti et al [24] reached similar conclusions. In addition, Rao et al [25] found an equivalent long-term cure with biopsy plus radiation versus resection plus radiation in patients with stage IE disease.…”
Section: Initial Surgical Treatment
supporting
confidence: 71%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our results showed an 88% 5-year disease-free survival, which com pares favorably with the results reported for other patients with stage IE disease (most with intermediate histology) treated with various regimens during a similar time peri od [11,12,23,24], Optimal treatment for patients with intermediate histology is unresolved. In contrast to the report of Valicenti et al [24], in which most of the patients had local failure, our results showed that these patients had distant failure, suggesting that there may be a role for systemic treatment.…”
Section: Intermediate-histology Lymphoma
supporting
confidence: 79%
“…The results reported by Maor et al [11] and Burgers et al [ 19] are comparable to the results of series in which patients underwent gastrectomy with or without adjuvant treatment [2.4,9,10,12,15,20-23] and suggest that initial management with radiation with or without chemotherapy may produce comparable diseasefree survival and overall survival as compared with regi mens that include surgical treatment. Both Taal et al [12] and Valicenti et al [24] reached similar conclusions. In addition, Rao et al [25] found an equivalent long-term cure with biopsy plus radiation versus resection plus radiation in patients with stage IE disease.…”
Section: Initial Surgical Treatment
supporting
confidence: 71%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Maor et al have reported an encouraging prognosis for patients with Stage I E and II E PGL, who were treated with alternating CHOP-Bleo and radiotherapy (22). Some authors have also found similar results for patients treated with chemo therapy and/or radiotherapy and those treated with pri mary surgery (3,20,23). Others have even proposed radiotherapy as the primary mode of treatment for PGL (24, 25).…”
Section: Introduction
supporting
confidence: 57%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the next chapter we return to the included studies and consider their findings. Cahn et al 1996 (85) Chak et al 1995 (86) Dill et al 1995 (87) Felt-Bersma et al 1996 (88) Herzog et al 1994 (89) Meyenberger et al 1996 (90) Mosnier et al 1990 (91) Motoo et al 1995 (92) Nakao et al 1994 (93) Nickl and Cotton 1990 (94) Nielsen et al 1993 (95) Nielsen et al 1994 (96) Solomon et al 1994 (97) Taal et al 1989 (98) Tio et al 1994 (99) Total 1 7 8…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our results showed an 88% 5-year disease-free survival, which com pares favorably with the results reported for other patients with stage IE disease (most with intermediate histology) treated with various regimens during a similar time peri od [11,12,23,24], Optimal treatment for patients with intermediate histology is unresolved. In contrast to the report of Valicenti et al [24], in which most of the patients had local failure, our results showed that these patients had distant failure, suggesting that there may be a role for systemic treatment.…”
Section: Intermediate-histology Lymphoma
supporting
confidence: 79%
“…The results reported by Maor et al [11] and Burgers et al [ 19] are comparable to the results of series in which patients underwent gastrectomy with or without adjuvant treatment [2.4,9,10,12,15,20-23] and suggest that initial management with radiation with or without chemotherapy may produce comparable diseasefree survival and overall survival as compared with regi mens that include surgical treatment. Both Taal et al [12] and Valicenti et al [24] reached similar conclusions. In addition, Rao et al [25] found an equivalent long-term cure with biopsy plus radiation versus resection plus radiation in patients with stage IE disease.…”
Section: Initial Surgical Treatment
supporting
confidence: 71%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Maor et al have reported an encouraging prognosis for patients with Stage I E and II E PGL, who were treated with alternating CHOP-Bleo and radiotherapy (22). Some authors have also found similar results for patients treated with chemo therapy and/or radiotherapy and those treated with pri mary surgery (3,20,23). Others have even proposed radiotherapy as the primary mode of treatment for PGL (24, 25).…”
Section: Introduction
supporting
confidence: 57%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the next chapter we return to the included studies and consider their findings. Cahn et al 1996 (85) Chak et al 1995 (86) Dill et al 1995 (87) Felt-Bersma et al 1996 (88) Herzog et al 1994 (89) Meyenberger et al 1996 (90) Mosnier et al 1990 (91) Motoo et al 1995 (92) Nakao et al 1994 (93) Nickl and Cotton 1990 (94) Nielsen et al 1993 (95) Nielsen et al 1994 (96) Solomon et al 1994 (97) Taal et al 1989 (98) Tio et al 1994 (99) Total 1 7 8…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our results showed an 88% 5-year disease-free survival, which com pares favorably with the results reported for other patients with stage IE disease (most with intermediate histology) treated with various regimens during a similar time peri od [11,12,23,24], Optimal treatment for patients with intermediate histology is unresolved. In contrast to the report of Valicenti et al [24], in which most of the patients had local failure, our results showed that these patients had distant failure, suggesting that there may be a role for systemic treatment.…”
Section: Intermediate-histology Lymphoma
supporting
confidence: 79%
“…The results reported by Maor et al [11] and Burgers et al [ 19] are comparable to the results of series in which patients underwent gastrectomy with or without adjuvant treatment [2.4,9,10,12,15,20-23] and suggest that initial management with radiation with or without chemotherapy may produce comparable diseasefree survival and overall survival as compared with regi mens that include surgical treatment. Both Taal et al [12] and Valicenti et al [24] reached similar conclusions. In addition, Rao et al [25] found an equivalent long-term cure with biopsy plus radiation versus resection plus radiation in patients with stage IE disease.…”
Section: Initial Surgical Treatment
supporting
confidence: 71%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Maor et al have reported an encouraging prognosis for patients with Stage I E and II E PGL, who were treated with alternating CHOP-Bleo and radiotherapy (22). Some authors have also found similar results for patients treated with chemo therapy and/or radiotherapy and those treated with pri mary surgery (3,20,23). Others have even proposed radiotherapy as the primary mode of treatment for PGL (24, 25).…”
Section: Introduction
supporting
confidence: 57%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the next chapter we return to the included studies and consider their findings. Cahn et al 1996 (85) Chak et al 1995 (86) Dill et al 1995 (87) Felt-Bersma et al 1996 (88) Herzog et al 1994 (89) Meyenberger et al 1996 (90) Mosnier et al 1990 (91) Motoo et al 1995 (92) Nakao et al 1994 (93) Nickl and Cotton 1990 (94) Nielsen et al 1993 (95) Nielsen et al 1994 (96) Solomon et al 1994 (97) Taal et al 1989 (98) Tio et al 1994 (99) Total 1 7 8…”
Section: Results
mentioning
confidence: 99%